Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

December 21, 2020

Primary Completion Date

August 18, 2021

Study Completion Date

August 18, 2021

Conditions
Atopic DermatitisPlaque Psoriasis
Interventions
DRUG

PF-07038124 ointment

PF-07038124 ointment at 0.01% with QD dosing for 6 weeks

DRUG

Vehicle ointment

Vehicle ointment with QD dosing for 6 weeks

Trial Locations (29)

2035

Australian Clinical Research Network, Maroubra

3124

Emeritus Research, Camberwell

27612

M3 Wake Research, Inc., Raleigh

32801

Clinical Neuroscience Solutions, Orlando

33166

Moonshine Research Center, Inc., Doral

33613

Center for Clinical Studies, Tampa

33756

Olympian Clinical Research, Clearwater

33991

Renaissance Research and Medical Group, Cape Coral

38119

Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Memphis

46168

The Indiana Clinical Trials Center, PC, Plainfield

46250

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

48202

Henry Ford Medical Center, New Center One, Detroit

77004

Center for Clinical Studies, Houston

77433

studies in Dermatology, LLC, Cypress

77598

Center for Clinical Studies, LTD. LLP, Webster

92708

First OC Dermatology, Fountain Valley

97210

Oregon Dermatology and Research Center, Portland

L8N 1Y2

Dermatrials Research Inc., Hamilton

L3P 1X3

Lynderm Research Inc., Markham

L5H 1G9

DermEdge Research, Mississauga

H2X 2V1

Innovaderm Research Inc., Montreal

G1V 4X7

Centre de Recherche Dermatologique du Quebec metropolitain, Québec

15-453

NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL, Bialystok

05-825

Mazowieckie Centrum Badań Klinicznych, Grodzisk Mazowiecki

40-611

Centrum Medyczne Angelius Provita, Katowice

90-242

Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna, Lodz

27-400

Dermedic Jacek Zdybski, Ostrowiec Świętokrzyski

35-055

Kliniczny Szpital Wojewódzki nr 1 im. F. Chopina w Rzeszowie, Rzeszów

02-793

ETG Warszawa, Warsaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04664153 - Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis | Biotech Hunter | Biotech Hunter